Cargando…

Risk factors associated with Retinopathy of Prematurity development and progression

Several studies propose that Retinopathy of Prematurity (ROP) is a multifactorial disorder implicating many prenatal and postnatal factors. The objective of our study was to determine the incidence and the risk factors that influenced ROP development and progression. We retrospectively compiled data...

Descripción completa

Detalles Bibliográficos
Autores principales: de las Rivas Ramírez, Nieves, Luque Aranda, Guillermo, Rius Díaz, Francisca, Pérez Frías, Francisco Javier, Sánchez Tamayo, Tomás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767907/
https://www.ncbi.nlm.nih.gov/pubmed/36539470
http://dx.doi.org/10.1038/s41598-022-26229-4
_version_ 1784854056640970752
author de las Rivas Ramírez, Nieves
Luque Aranda, Guillermo
Rius Díaz, Francisca
Pérez Frías, Francisco Javier
Sánchez Tamayo, Tomás
author_facet de las Rivas Ramírez, Nieves
Luque Aranda, Guillermo
Rius Díaz, Francisca
Pérez Frías, Francisco Javier
Sánchez Tamayo, Tomás
author_sort de las Rivas Ramírez, Nieves
collection PubMed
description Several studies propose that Retinopathy of Prematurity (ROP) is a multifactorial disorder implicating many prenatal and postnatal factors. The objective of our study was to determine the incidence and the risk factors that influenced ROP development and progression. We retrospectively compiled data of preterms with birth weight (BW) ≤ 1.500 g and/or gestational age (GA) < 32 weeks, or BW between 1.501 and 2.000 g and/or GA ≥ 32 weeks with oxygen supply > 72 h or unstable clinical course screened for ROP in Regional University Hospital of Málaga from 2015 to 2018. 202 infants (44.7%) developed ROP and 66 exhibited progression (32.7% of ROP infants). In the univariate analysis, many risk factors were associated with ROP. In the subsequent multivariate analysis, GA, oxygen therapy and weight at 28 days of life, mechanical ventilation duration, non-invasive ventilation, surfactant administration and late-onset sepsis were independently associated with the development. However, oxygen therapy duration, late-onset sepsis and weight at 28 days were associated with the progression. The ROP development and progression risk factors were different. Our results are important to facilitate screening, early diagnosis and ROP treatment while reducing unneeded examinations.
format Online
Article
Text
id pubmed-9767907
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97679072022-12-22 Risk factors associated with Retinopathy of Prematurity development and progression de las Rivas Ramírez, Nieves Luque Aranda, Guillermo Rius Díaz, Francisca Pérez Frías, Francisco Javier Sánchez Tamayo, Tomás Sci Rep Article Several studies propose that Retinopathy of Prematurity (ROP) is a multifactorial disorder implicating many prenatal and postnatal factors. The objective of our study was to determine the incidence and the risk factors that influenced ROP development and progression. We retrospectively compiled data of preterms with birth weight (BW) ≤ 1.500 g and/or gestational age (GA) < 32 weeks, or BW between 1.501 and 2.000 g and/or GA ≥ 32 weeks with oxygen supply > 72 h or unstable clinical course screened for ROP in Regional University Hospital of Málaga from 2015 to 2018. 202 infants (44.7%) developed ROP and 66 exhibited progression (32.7% of ROP infants). In the univariate analysis, many risk factors were associated with ROP. In the subsequent multivariate analysis, GA, oxygen therapy and weight at 28 days of life, mechanical ventilation duration, non-invasive ventilation, surfactant administration and late-onset sepsis were independently associated with the development. However, oxygen therapy duration, late-onset sepsis and weight at 28 days were associated with the progression. The ROP development and progression risk factors were different. Our results are important to facilitate screening, early diagnosis and ROP treatment while reducing unneeded examinations. Nature Publishing Group UK 2022-12-20 /pmc/articles/PMC9767907/ /pubmed/36539470 http://dx.doi.org/10.1038/s41598-022-26229-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
de las Rivas Ramírez, Nieves
Luque Aranda, Guillermo
Rius Díaz, Francisca
Pérez Frías, Francisco Javier
Sánchez Tamayo, Tomás
Risk factors associated with Retinopathy of Prematurity development and progression
title Risk factors associated with Retinopathy of Prematurity development and progression
title_full Risk factors associated with Retinopathy of Prematurity development and progression
title_fullStr Risk factors associated with Retinopathy of Prematurity development and progression
title_full_unstemmed Risk factors associated with Retinopathy of Prematurity development and progression
title_short Risk factors associated with Retinopathy of Prematurity development and progression
title_sort risk factors associated with retinopathy of prematurity development and progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767907/
https://www.ncbi.nlm.nih.gov/pubmed/36539470
http://dx.doi.org/10.1038/s41598-022-26229-4
work_keys_str_mv AT delasrivasramireznieves riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression
AT luquearandaguillermo riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression
AT riusdiazfrancisca riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression
AT perezfriasfranciscojavier riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression
AT sancheztamayotomas riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression